Tag: TriSalus Life Sciences
TriSalus releases real-world data showing success for pressure-enabled drug delivery
TriSalus Life Sciences, an oncology company integrating delivery technology with immunotherapy in the treatment of patients with liver and pancreatic tumours, today announced the...
First patient enrolled in PERIO-02 trial of SD-101 delivery via pressure-enabled...
TriSalus Life Sciences announced the enrolment of the first patient in its Pressure-Enabled Regional Immuno-Oncology (PERIO-02) clinical study in a press release.
The trial is...
CMS Transitional Pass-Through Payment programme paves the way for cutting-edge treatments
This advertorial is sponsored by TriSalus Life Sciences.
NOTE: This article is intended only for healthcare professionals in the USA.
The Medicare Transitional Pass-Through Payment (TPT)...
